Fabrication and characterization of prednisolone acetate-loaded electrospun mucoadhesive nanofibers for treatment of oral lichen planus
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-05 · 399 (8) · 12539-12557
DOI: 10.1007/s00210-026-05189-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 16.03.2026. Verfasst von Sachin und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India. Hauptthemen laut MEDLINE: Nanofibers, Prednisolone, Lichen Planus, Oral, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Oral lichen planus (OLP), a chronic inflammatory disease affecting the stratified squamous epithelium of oral mucosa (mucositis), presents treatment challenges due to rapid washout of conventional topical gels. This study developed prednisolone acetate-loaded mucoadhesive electrospun nanofibers using PVP K90/Eudragit RS100 via Super ES-3 technology to enhance drug retention and therapeutic efficacy. Nanofibers exhibited uniform morphology (diameter ranging from185 ± 0.3 nm to 704 ± 0.3 nm), neutral surface pH (7.4 ± 0.1), and superior mucoadhesion of 0.03N and bond strength of 0.455 Nmm2. FTIR confirmed polymer-drug compatibility and XRD studies revealed crystalline state of drug in nanofibers. In vitro release from prednisolone acetate-loaded nanofibers followed zero-order kinetics (r2 = 0.999, RMSE = 1.02%, 90.21% Q₁₂ₕ), ideal for sustained delivery vis a vis. prednisolone acetate dispersion that followed Korsmeyer-Peppas model (r2 = 0.962, RMSE = 3.99, 51.34% Q12h). In vivo evaluations using 4% SDS-induced mucosal irritation model in Wistar rats shown irritation score of 4.333 ± 0.58 in disease control, nanofibers achieved near-complete resolution (score 1.000 ± 0.58, equivalent to vehicle p = 0.7538), significantly outperforming marketed formulation (3.000 ± 0.58, p = 0.0015; using one-way ANOVA F = 45.2, p < 0.0001). Histopathology confirmed superiority with no signs of irritation or tissue damage of the oral mucosa showing normalized rete ridges and minimal inflammation. These findings demonstrate mucoadhesive nanofibers as a promising localized delivery system for OLP, providing sustained prednisolone acetate release, prolonged buccal retention of 7 h, and superior therapeutic outcomes while minimizing systemic corticosteroid exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India.
- School of Medicine and Dentistry, Griffith University, Gold Coast, QLD, 4222, Australia.
- School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India. aman.rai14@gmail.com.
ORCID-Profile: Sachin, Jagjit Singh Dhaliwal, Amanpreet Kaur
Zitieren
APA
Sachin, Dhaliwal, J. S., & Kaur, A. (2026). Fabrication and characterization of prednisolone acetate-loaded electrospun mucoadhesive nanofibers for treatment of oral lichen planus. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(8), 12539-12557. https://doi.org/10.1007/s00210-026-05189-w
Vancouver
Sachin, Dhaliwal JS, Kaur A. Fabrication and characterization of prednisolone acetate-loaded electrospun mucoadhesive nanofibers for treatment of oral lichen planus. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(8):12539-12557. doi:10.1007/s00210-026-05189-w
BibTeX
@article{Sachin2026,
author = {Sachin and Dhaliwal, Jagjit Singh and Kaur, Amanpreet},
title = {Fabrication and characterization of prednisolone acetate-loaded electrospun mucoadhesive nanofibers for treatment of oral lichen planus},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {8},
pages = {12539--12557},
doi = {10.1007/s00210-026-05189-w}
}
EUVIMED